N(G)-monomethyl-L-arginine inhibits erythropoietin gene expression by stimulating GATA-2

Blood

Volumn 96, Issue 5, 2000, Pages 1716-1722

  Tarumoto, T ^a   Imagawa, S ^a   Ohmine, K ^a   Nagai, T ^a   Higuchi, M ^a   Imai, N ^a   Suzuki, N ^a   Yamamoto, M ^a   Ozawa, K ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; ERYTHROPOIETIN; LUCIFERASE; N(G) METHYLARGININE; TRANSCRIPTION FACTOR GATA 2;

ARTICLE; DRUG INHIBITION; ELECTROPHORETIC MOBILITY; ENHANCER REGION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; UREMIA;

EID: 0034283995     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.5.1716     Document Type: Article

References (37)

1. Oxygen sensing and molecular adaptation to hypoxia
2. Liver as the primary site of erythropoietin formation in the fetus
3. Role of the kidney in erythropoiesis
4. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney
5. Erythropoietin deficiency and erythropoiesis in renal insufficiency
6. Anemia of end-stage renal disease
7. Erythropoietin-hematocrit feedback circuit in the anemia of end-stage renal disease
8. Accumulation of the endogenous L-arginine analogue N(G)-monomethyI-L arginine in human end-stage renal failure patients on regular haemodialysis
9. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anesthetized rats
10. Negative regulation of the erythropoietin gene expression by the GATA transcription factors
11. Regulatory elements of the erythropoieitin gene
12. Activity and tissue-specific expression of the transcription factor NF-E1 multi gene family
13. Transcription factor GATA-2 is expressed in erythroid, early myeloid, and CD34+ human leukemia-derived cell lines
14. Hypoxic induction of the human erythropoietin gene: Cooperation between the promoter and enhancer, each of which contains steroid receptor response elements
15. Luciferase reporter gene vectors for analysis of promoters and enhancers
16. The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1
17. Expression of δ-aminolevulinate syntase in avian cells: Separate genes encode erythroid specific and nonspecific isozymes
18. A novel rapid assay for chloramphenicol acetyltransferase gene expression
19. A fluorometric assay for the measurement of nitrite in biological samples
20. Increased secretion of erythropoietin in human renal carcinoma cells in response to hypoxia
21. Interaction of nitric oxide and cyclic guanosine 3',5'-monophosphate in erythropoietin production
22. Nitric oxide: Physiology, pathology, and pharmacology
23. Detection of N(G), N(G)-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody
24. Detection of N(G), N(G)-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody
25. Purification and properties of a new enzyme, N(G), N(G)-dimethylarginine dimethylaminohydrolase, from rat kidney
26. Endothelial cells metabolize N(G)-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine
27. Endothelium-derived nitric oxide: Actions and propedies
28. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
29. Isoform of nitric oxide: Characterization and purification from different cell types
30. Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate
31. Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics
32. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
33. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
34. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
35. 2-dependent degradation domain via the ubiquitin-proteasome pathway
36. Inhibition of hypoxiainducible factor 1 activity by nitric oxide donors in hypoxia